Review Article
Volume 9 Issue 11 - 2020
Anemia of Chronic Disease in Saudi Arabia
Turki Abdulaziz Al Shuaibi1*, Abdulsalam Abdulmohsen Almofadhi2, Hassan Ahmed Alkhuzai3, Mansour Mari Aboshahran4, Ghadah Abdulrhman Burid5, Faisal Abdullah Alamri4, Mesedah Abdullah Alnahdi6, Bander Hail Alanizy7, Hamad Abdulrahman Alrasheedi8, Hassan Gharamah Alasmari9 and Ahmed Abdullah Alharbi3
1Consultant of Internal Medicine and Hematology, King Fahad General Hospital, Jeddah, Saudi Arabia
2King Salman Specialist Hospital, Hail, Saudi Arabia
3Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia
4King Khalid University, Abha, Saudi Arabia
5King Abdulaziz University, Jeddah, Saudi Arabia
6King Salman Hospital, Riyadh, Saudi Arabia
7Alfarabi Colleges of Medicine, Riyadh, Saudi Arabia
8University of Hail, Hail, Saudi Arabia
9Taif University, Taif, Saudi Arabia
*Corresponding Author: Turki Abdulaziz Al Shuaibi, Consultant of Internal Medicine and Hematology, King Fahad General Hospital, Jeddah, Saudi Arabia.
Received: October 13, 2020; Published: October 22, 2020




Abstract

Background: Anemia of chronic disease (ACD) means that autoimmune disorders in which the body’s immune system attacks joints and/or organ or other chronic diseases that lasts more than 3 months cause low blood cell levels. ACD occurs in patients with active immune or inflammatory response in their current conditions that leads to a decreased intake of iron at different locations but not to patients who are specifically anemic with their diseases or treatments such as certain malignancies and the use of cytotoxic medications.

Aim: The aim of this paper is to review the prevalence of ACD in Saudi Arabia, highlight pathogenesis, diagnosis and management of ACD in Saudi Arabia.

Conclusion: Understanding of ACD and its management among public Saudi population especially in patients with one or more chronic disease is important to control ACD prevalence in Saudi Arabia. Health education sessions and training courses for physicians and chronic disease patients should be conducted to increase health awareness about this growing problem.

Keywords: Anemia of Chronic Diseases; ACD; ACD in Saudi Arabia; Diagnosis of ACD

References

  1. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity (2011).
  2. https://my.clevelandclinic.org/com
  3. Weiss G and Goodnough LTN. “Anemia of chronic disease”. The New England Journal of Medicine 10 (2005): 1011-1023.
  4. Weiss G. “Iron metabolism in the anemia of chronic disease”. Biochimica et Biophysica Acta 7 (2009): 682-693.
  5. Means RT Jr. “Recent developments in the anemia of chronic disease”. Current Hematology Reports 2 (2003): 116-121.
  6. Means RT. “Approach to the anemias”. In: Goldman L, Schafer AI, editions. Goldman-Cecil Medicine. 26th Philadelphia, PA: Elsevier (2020): 149.
  7. Memish ZA., et al. “Obesity and associated factors--Kingdom of Saudi Arabia, 2013”. Preventing Chronic Disease (2014).
  8. https://europepmc.org/
  9. Gaspar BL., et al. “Anemia in malignancies: pathogenetic and diagnostic considerations”. Hematology 1 (2015): 18-25.
  10. Justyna Przybyszewska., et al. “Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia”. Polskie Archiwum Medycyny Wewnetrznej 3 (2013): 105-111.
  11. https://www.mayoclinic.org/diseases-conditions/anemia/diagnosis-treatment/drc-20351366
  12. El Bcheraoui C., et al. “Hypertension and its associated risk factors in the kingdom of Saudi Arabia, 2013: a national survey”. International Journal of Hypertension (2014): 564679.
  13. Ahmed AM., et al. “Cardiovascular risk factors burden in Saudi Arabia: The Africa Middle East Cardiovascular Epidemiological (ACE) study”. Journal of the Saudi Heart Association 4 (2017): 235-243.
  14. Alqurashi KA., et al. “Prevalence of diabetes mellitus in a Saudi community”. Annals of Saudi Medicine 1 (2011): 19-23.
  15. Al-Hazzaa HM. “Prevalence of physical inactivity in Saudi Arabia: a brief review”. East Mediterranean Health Journal 4-5 (2004): 663-670.
  16. Food Consumption: Food and Agriculture Organization of United Nation (2011).
  17. United Nations. “Desa Population Division”. World Population Prospects (2017).
  18. Weiss G. “Pathogenesis and treatment of anaemia of chronic disease”. Blood Reviews 2 (2002): 87-89.
  19. Jurado RL. “Iron, infections, and anemia of inflammation”. Clinical Infectious Diseases 4 (1997): 888-895.
  20. Cartwright G E. “The anemia of chronic disorders”. Seminars in Hematology 4 (1966): 351-375.
  21. Ganz TB. “Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation”. Blood 3 (2003): 783.
  22. Ganz T., et al. “Immunoassay for human serum hepcidin”. Blood10 (2008): 4292-4297.
  23. Ferguson BJ., et al. “Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia”. Journal of Laboratory and Clinical Medicine 4 (1992): 385-390.
  24. World Health Organization, Centers for Disease Control. Assessing the iron status of populations: Report of a joint WHO/CDC Technical Consultation on the assessment of iron status at the population level (2011).
  25. Looker AC., et al. “Increased serum transferrin saturation is associated with lower serum transferrin receptor concentration”. Clinical Chemistry 12 (1999): 2191-2199.
  26. Wians FH Jr., et al. “Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration”. American Journal of Clinical Pathology 1 (2001): 112-118.
  27. Guyatt GH., et al. “Laboratory diagnosis of iron-deficiency anemia: an overview”. Journal of General Internal Medicine 2 (1992): 145-153.
  28. https://www.niddk.nih.gov/health-information/blood-diseases/anemia-inflammation-chronic-disease
  29. Hentze MW., et al. “Balancing acts: molecular control of mammalian iron metabolism”. Call3 (2004): 285-297.
  30. Mc Cranor BJ., et al. “Nterleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells”. Blood Cells, Molecules and Diseases 2-3 (2014): 126-133.
  31. Ganz T., et al. “Immunoassay for human serum hepcidin”. Blood10 (2008): 4292-4297.
  32. Capocasale RJ., et al. “Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice”. Cytometry A2 (2008): 148-159.
  33. Raj DS. “Role of interleukin-6 in the anemia of chronic disease”. Seminars in Arthritis and Rheumatism 5 (2009): 382-388.
  34. Mc Cranor BJ., et al. “Nterleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells”. Blood Cells, Molecules and Diseases 2-3 (2014): 126-133.
  35. Vokurka M., et al. “Hepcidin expression in the liver of mice with implanted tumour reacts to iron deficiency, inflammation and erythropoietin administration”. Folia Biologica 6 (2011): 248-254.
  36. Besson-Fournier C., et al. “Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling”. Blood2 (2012): 431-439.
  37. Koulaouzidis A., et al. “Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review”. The Journal of Gastrointestinal and Liver Diseases 18 (2009): 345-352.
  38. Skikne BS., et al. “Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index”. American Journal of Hematology 86 (2011): 923-927.
  39. Thomas C and Thomas L. “Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency”. Clinical Chemistry 48 (2002): 1066-1076.
  40. Collins JF., et al. “Hepcidin regulation of iron transport”. Journal of Nutrition 11 (2008): 2284-2288.
  41. Zhang S., et al. “Disordered hepcidin-ferroportin signaling promotes breast cancer growth”. Cell Signaling 11 (2014): 2539-2550.
  42. Xu X., et al. “Celecoxib attenuates cachectic events in mice by modulating the expression of vascular endothelial growth factor”. Molecular Medicine Reports 1 (2015): 289-294.
  43. Mei S., et al. “Hepcidin and GDF15 in anemia of multiple myeloma”. International Journal of Hematology 3 (2014): 266-273.
  44. Vokurka M., et al. “Hepcidin expression in the liver of mice with implanted tumour reacts to iron deficiency, inflammation and erythropoietin administration”. Folia Biologica6 (2011): 248-254.
  45. Przybyszewska J., et al. “Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia”. Polskie Archiwum Medycyny Wewnetrznej 3 (2013): 105-111.
  46. Madu AJ and Ughasoro MD. “Anaemia of Chronic Disease: An In-Depth Review”. Medical Principles and Practice 1 (2017): 1-9.
  47. Nairz M., et al. “Iron at the interface of immunity and infection”. Frontiers in Pharmacology 5 (2014): 152.
  48. Kennedy RB., et al. “Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients”. Immunogenetics7-8 (2014): 493-499.
  49. Blumenstein I., et al. “Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemI BD Study”. Journal of Crohn's and Colitis 10 (2014): 1308-1314.
  50. De Lima GA., et al. “Anemia in chronic renal disease: evaluation of inflammatory activity on erythropoiesis and iron metabolism in patients not submitted to dialysis treatment”. Clinical Laboratory 7-8 (2012): 695-704.
  51. Miyazono K., et al. “Bone morphogenetic protein receptors and signal transduction”. Journal of Biochemistry 1 (2010): 35-51.
  52. Herfs R., et al. “Treatment of Iron Deficiency with or without Anaemia with Intravenous Ferric Carboxymaltose in Gynaecological Practices - A Non-Interventional Study”. Geburtshilfe Frauenheilkd1 (2014): 81-88.
  53. Kennedy RB., et al. “Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients”. Immunogenetics7-8 (2014): 493-499.
  54. Shu T., et al. “Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis”. European Journal of Haematology 94 (2015): 67-73.
  55. Nairz M., et al. “Iron at the interface of immunity and infection”. Frontiers in Pharmacology 5 (2014): 152.
Citation: Turki Abdulaziz Al Shuaibi., et al. “Anemia of Chronic Disease in Saudi Arabia”. EC Gynaecology 9.11 (2020): 59-66.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.